Cinven to buy pharmaceutical-research contractor for $915M

|By:, SA News Editor

Cinven has agreed to acquire Medpace, a pharmaceutical-research outsourcing company, for $915M from CCMP Capital Advisors.

Medpace has 1,500 employees in over 45 countries and generated $94M in adjusted core earnings last year.

The deal is the latest in the sector between private-equity firms. The market for companies  such as Medpace is growing, due to the increasing need of drug firms to outsource clinical studies.